Mary T. Szela, Senior Vice President at ABBOTT LABORATORIES (ABT), sold 8,122 shares at $41.57 ($338K) on 2009-05-01, disclosed to the SEC on 2009-05-05.
Scheduled sale ($338k) by Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| TLSI | SELL | 2026-03-20 | $79K | — | Filing → |
| TLSI | BUY | 2026-02-23 | $125K | — | Filing → |
| TLSI | BUY | 2025-01-31 | $52K | — | Filing → |